KKKeshia Kroh

Keshia Kroh

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Keshia Kroh has a total of 32 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Langerhans cells as targets of rabies virus immune evasion

    by Keshia Kroh, Leanne C. Helgers, Teunis B. H. Geijtenbeek, Carmen W. E. Embregts, Corine H. GeurtsvanKessel

    Rabies virus (RABV) is a neurotropic virus of the genus Lyssavirus that causes a nearly always fatal encephalitis in humans once it reaches the central nervous system. Dog bites are a major transmission route of RABV, and following superficial skin exposure, RABV first encounters epidermal Langerhans cells (LCs), yet their role in early infection remains poorly understood. Here, we show that exposure of immature human epidermal LCs to RABV leads to RABV association with cells in the absence of productive viral replication. RABV-exposed LCs display reduced cytokine and type I IFN responses and lack induction of IFN-stimulated genes, indicating suppression of antiviral signalling pathways. Together, these findings suggest that RABV is efficiently taken up by immature LCs, which dampens the antiviral immune responses of LCs, potentially facilitating immune evasion at the skin entry site.

  • Open Access

    Rabies virus infection and immune activation in human epidermal keratinocytes: Implications for rabies transmission

    by Keshia Kroh, Alisha D. Biharie, Eleanor M. Marshall, Redwan Rahmat, Debby Schipper, Leanne C. Helgers, Teunis B.H. Geijtenbeek, Corine H. GeurtsvanKessel, Carmen W.E. Embregts


  • Open Access

    Immunohistochemical investigation of canine lymph nodes collected during a rabies outbreak in South Africa

    by Redwan Rahmat, Matthijs F. Ravensberg, Debby Schipper, Keshia Kroh, Edwin J.B. Veldhuis Kroeze, Thijs Kuiken, Claude Sabeta, Corine H. GeurtsvanKessel, Carmen W.E. Embregts

    Rabies is a fatal zoonosis that impairs host immune function, yet effects on peripheral lymphoid architecture are poorly defined. During a 2021–2022 rabies virus (RABV) outbreak in South Africa, we collected cervical lymph nodes from 36 rabies-suspect dogs; RABV RNA was detected in 27. Canine distemper virus RNA was detected in a subset across both RABV-positive (RABV+) and RABV-negative (RABV−) groups and was not associated with clinical-sign count. We set up a computer-assisted histological analysis tool to quantify germinal-centre (GC) nucleus density and immunohistochemistry for CD20, PNA and IBA1 to profile B cells, GC activity and macrophages. Within the outbreak cohort, GC density and marker-based metrics did not differ between RABV+ and RABV− dogs. Two healthy dogs were included as reference tissues; values in outbreak dogs were generally lower, but these contrasts are contextual given the limited, non-matched controls. This study provides a reproducible framework for quantifying immune cell organization in field-collected tissues during natural RABV exposure and highlights the need for larger, geographically matched control groups and complementary functional immune measurements.

  • Open Access

    The role of extracellular vesicle fusion with target cells in triggering systemic inflammation

    by Praveen Papareddy, Ines Tapken, Keshia Kroh, Ravi Kiran Varma Bhongir, Milladur Rahman, Maria Baumgarten, Eda Irem Cim, Lilla Györffy, Emanuel Smeds, Ariane Neumann, et al.

    Extracellular vesicles (EVs) play a crucial role in intercellular communication by transferring bioactive molecules from donor to recipient cells. As a result, EV fusion leads to the modulation of cellular functions and has an impact on both physiological and pathological processes in the recipient cell. This study explores the impact of EV fusion on cellular responses to inflammatory signaling. Our findings reveal that fusion renders non-responsive cells susceptible to inflammatory signaling, as evidenced by increased NF-κB activation and the release of inflammatory mediators. Syntaxin-binding protein 1 is essential for the merge and activation of intracellular signaling. Subsequent analysis show that EVs transfer their functionally active receptors to target cells, making them prone to an otherwise unresponsive state. EVs in complex with their agonist, require no further stimulation of the target cells to trigger mobilization of NF-κB. While receptor antagonists were unable to inhibit NF-κB activation, blocking of the fusion between EVs and their target cells with heparin mitigated inflammation in mice challenged with EVs.